Funder
Bristol-Myers Squibb
Eli Lilly
Merck Sharp and Dohme
Novartis
Pfizer
Roche
Ministry of Economy
Health Research Fund (FIS)/European Regional Development Fund
Spanish Association Against Cancer (AECC) Scientific Foundation
Italian Association for Cancer Research
Fondazione Pezcoller
National Cancer Institute
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference131 articles.
1. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011
2. CT screening for lung cancer: significance of diagnoses in its baseline cycle;Henschke;Clin Imaging,2006
3. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval;Yousaf-Khan;Thorax,2017
4. De Koning H, Van Der Aalst C, ten Haaf K, Oudkerk M. Effects of volume CT lung cancer screening: mortality results of the NELSON randomized-controlled population trial. Paper presented at: 19th World Conference on Lung Cancer. September 23–26, 2018; Toronto, Canada.
5. European position statement on lung cancer screening;Oudkerk;Lancet Oncol,2017
Cited by
301 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献